Biomarin Pharmaceuticals (BMRN)

$91.20 0.00 (0.00%)

16:00 EDT BMRN Stock Quote Delayed 30 Minutes

BMRN Stock Earnings: Biomarin Pharmaceutical Beats EPS, Misses Revenue for Q1 2024

By InvestorPlace Earnings Apr 24, 2024

BMRN stock results show that Biomarin Pharmaceutical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

7 Biotech Stocks Fighting America’s Deadliest Diseases

If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names

Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures

Volume:

Previous Close -

Market Cap 16.72B

PE Ratio 104.83

EPS 0.87

Volume (Avg. Vol.) 29

Day's Range -

52-Week Range $76.02 - $99.56

Dividend & Yield N/A (N/A)

BMRN Stock Predictions, Articles, and Biomarin Pharmaceuticals News

From InvestorPlace
From the Web

3 Promising Biotech Stocks Flying Under the Radar

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Nov 8, 2023

Breakthroughs in healthcare are happening everyday, make sure you are keeping up to date on these under the radar biotech stocks.

BMRN Stock Jumps 12% as Activist Elliott Targets BioMarin Pharmaceuticals

By Chris MacDonald, InvestorPlace Contributor Nov 7, 2023

Shares of BMRN stock are on the move today as activist investor Elliott Investment Management builds a position in this drugmaker.

3 Biotech Stocks to Make Your ‘Get Rich’ Dreams Come True

By Muslim Farooque, InvestorPlace Contributor Jul 6, 2023

These high return biotech stocks offer tremendous upside ahead and are likely to soar on the back of several growth drivers

3 Biotech Stocks to Buy With Explosive Upside Potential

By Alex Sirois, InvestorPlace Contributor Jun 22, 2023

These three biotech stocks with high upside potential also display some significant risk, but less so than many of their small-cap peers.

3 Biotech Stocks That Could Skyrocket in the Next 12 Months

By Muslim Farooque, InvestorPlace Contributor Jun 7, 2023

These promising biotech stocks are risky but offer tremendous upside generating stellar long-term returns in the upcoming 12 months.

3 Biotech Stocks With Blockbuster Potential

By Josh Enomoto, InvestorPlace Contributor May 24, 2023

Although risky, these biotech stocks with blockbuster potential may skyrocket should regulatory winds favor their therapeutics.

7 Biotech Stocks That Could Cure Your Portfolio Woes

By Josh Enomoto, InvestorPlace Contributor Apr 19, 2023

If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill.

3 Drug Stocks With Promising Pipelines for 2023

By Alex Sirois, InvestorPlace Contributor Jan 23, 2023

These 3 drug stocks with promising pipelines are in position to reward investors in 2023 due to multiple factors.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Dec 1, 2022

Good morning! We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about!

7 Potential Biotech Stocks Buyout Targets in 2022

By Shanthi Rexaline Apr 21, 2022

Big biopharma companies usually rely on M&A to get immediate access to a new class of drug or technology, fill in the gap in their pipeline and compensate for revenue loss from patent expiration of blockbuster products.

7 Pharmaceutical Stocks Working on Their Next Blockbuster

By Alex Sirois, InvestorPlace Contributor Mar 12, 2021

Pharmaceutical stocks are a sector with unique success factors. One factor is developing blockbuster drugs. These 7 are close.

5 Top Stock Trades for Thursday: TGT, LOW, V, BMRN, NVDA

By Bret Kenwell, InvestorPlace Contributor Aug 19, 2020

Nvidia, BioMarin, Visa, Lowe's and Target were our top stock trades. That said, let's look at what the charts are telling us now.

5 Strong Buy Biotech Stocks for the Second Half

By Harriet Lefton, Writer, TipRanks Jun 19, 2019

We are now approaching the second half of 2019. And it may be time for a little portfolio rebalancing. Biotech stocks often move independently from the market, and these 5 are worth a look.

5 Biotech Stocks That Could Face M&A Next!

By Aaron Levitt, InvestorPlace Contributor Jan 10, 2019

Big biotech buyouts have already started happening. These five biotech stocks could be the next to go.

18 Stocks That Could Be Takeover Targets

By Vince Martin, InvestorPlace Contributor Jul 10, 2018

These takeover stocks all look like promising takeover targets at a time when M&A activity is likely to pick up.

3 Biotech Stocks Up in the Past Month on Industry Turnaround

By Jun 15, 2018

We take a look at three biotech stocks whose share price has increased in the past month due to as the biotech industry bounced back in the past month after dec....

5 Biotech Stocks to Boost Your Portfolio’s Health This Year

By May 31, 2018

Though the biotech industry is down this year, there are still a few stocks which can strengthen your portfolio. Compare Brokers....

4 Biotech Stocks With Leaky Pipelines

By Regina Borsellino Apr 10, 2018

A strong pipeline can make or break biotech stocks, ensuring strong profits for years to come. These four biotech companies don't make the cut.

5 Biotech Stocks With Amazing Pipelines

By Regina Borsellino Mar 27, 2018

Biotech stocks are only as good as their pipeline. These five biotech companies are about to put out promising new drugs, with more products in the works.

Why BioMarin Pharmaceutical Inc. Stock Is Surging Today

By William White, InvestorPlace Writer Dec 11, 2017

BioMarin (BMRN) stock was on the rise today following positive news for its gene therapy efforts to treat severe hemophilia.

Biomarin Pharmaceuticals (BMRN)

BMRN Stock Earnings: Biomarin Pharmaceutical Beats EPS, Misses Revenue for Q1 2024

7 Biotech Stocks Fighting America’s Deadliest Diseases

If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names

Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Biomarin Pharmaceuticals (BMRN)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

BMRN Stock Predictions, Articles, and Biomarin Pharmaceuticals News

Subscriber Sign in